Both sleep and wakefulness in excess are signs of illness. Aphorism 5 th century BC H ippocrates, the father of Medicine, spoke of the importance of sleep through this wonderful aphorism. However, it can be said that it was only in 1929 that the modern era of sleep investigation began, with the description of the electrical activity of the human brain by the German psychiatrist Hans Berger, who created the term "electroencephalography". In Chicago in the 1930s, Loomis, Harvey and Hobart 1 conducted the first systematic studies of electroencephalographic patterns during human sleep. They reported that sleep was not a continuous process but was characterized by distinct activity patterns that alternated throughout the night in an almost predictable manner. . This is now undergoing revision for publication in 2014.
H ippocrates, the father of Medicine, spoke of the importance of sleep through this wonderful aphorism. However, it can be said that it was only in 1929 that the modern era of sleep investigation began, with the description of the electrical activity of the human brain by the German psychiatrist Hans Berger, who created the term "electroencephalography". In Chicago in the 1930s, Loomis, Harvey and Hobart 1 conducted the first systematic studies of electroencephalographic patterns during human sleep. They reported that sleep was not a continuous process but was characterized by distinct activity patterns that alternated throughout the night in an almost predictable manner. In 1953, rapid eye movement (REM) sleep was described formally by Aserinsky . This is now undergoing revision for publication in 2014.
Sleep disorders can be seen to have relevance to all fields of healthcare. Not only are these disorders highly prevalent, but also there is increasing knowledge of the repercussions of a bad night of sleep. For example, obstructive sleep apnea syndrome is currently one of the biggest public health problems, with welldefined cardiovascular risks.
Insomnia is a very frequent complaint in medical consultation offices of any specialty. A study on a Brazilian population 7 revealed that 35% of the individuals interviewed presented complaints of insomnia at least three times a week. However, despite all advances in knowledge, insomnia is still a challenge because of the generally complex nature of diagnostic and therapeutic approaches towards this condition. Its symptoms may result from various causes, such as use of medications, medical diseases, psychiatric disorders, poor sleep hygiene or primary sleep disorders, among others. Moreover, insomnia is a risk factor for mental and clinical disorders, substance and alcohol abuse and accidents. Around 57% of insomniac patients develop some kind of psychiatric condition. Insomnia is a predictive factor for a first episode of depression and for recurrence of depression and anxiety 8 . Therefore, when faced with a patient with a complaint of insomnia, careful investigation to identify factors that might be altering the patient's sleep is essential, so that the correct therapeutic measures are taken.
In this issue of Arquivos de Neuro-Psiquiatria, van der Mollen et al 9 present a wide-ranging review of primary insomnia, with emphasis on non-pharmacological treatment.
The authors firstly show the definition of insomnia as a symptom, which is important for its diagnostic comprehension. They then go beyond this by emphasizing the current view of insomnia in psychological terms (cognitive components and behavioral factors) and in physiological terms (high metabolic rate, with increased muscle tonus, heart rate and temperature). They also show the neurobiology of insomnia from two perspectives: one poin ting towards failure of inhibition of wakefulness and the other considering hyper-alertness to have an important role. Comprehension of these characteristics has a fundamental role in approaches towards primary insomnia. Spielman's 3P mo del 10 , through recognizing individuals who present a "chance" of having insomnia (Predisposing factors), factors that can trigger it (Precipitating factors) and factors that can perpe tuate it (Perpetuating factors), certainly also helps in ap plying nonpharmacological interventions. These are collec tively named cognitive-behavioral therapy for insomnia (CBT-i) and are increasingly being shown to be effective 11 . Together with drug treatment, CBT-i is considered to be the standard treatment. Over the long term, it shows greater efficacy because of changes to patients' habits and dysfunctional be liefs and thinking.
The authors make an excellent practical application of patients' complaints and the psychological and neurobiological aspects of insomnia, through correlations with the different types of CBTi. This review can certainly be recommended for all healthcare professionals, and reading it will certainly help not only in identifying the factors involved but also in directing the treatment. However, as written in the text, CBTi is not commonly used in clinics because of both the lack of information about this treatment and the scarcity of professionals with specific training in this field. We hope that articles like this will stimulate the growth of non-pharmacological therapy for insomnia within our setting.
